Fat Loss Peptide
AOD-9604
The anti-obesity peptide fragment
Starting at $280
AOD-9604 is a synthetic fragment of human growth hormone (amino acids 176–191) that mimics GH's fat-burning properties without affecting blood sugar or IGF-1 levels. It directly stimulates lipolysis and inhibits lipogenesis through a mechanism independent of the GH receptor.
Pure lipolysis. No metabolic disruption.
AOD-9604 targets fat metabolism specifically — producing the fat-burning benefits of GH without the blood sugar effects that make full GH inappropriate for many patients.
Fat Oxidation
Lipolysis Stimulation
AOD-9604 activates beta-3 adrenergic receptors in adipose tissue, triggering the breakdown of stored triglycerides into free fatty acids for use as fuel — directly targeting fat stores.
Result: Direct mobilization of stored fat for energy
Fat Storage Prevention
Lipogenesis Inhibition
Simultaneously inhibits the creation of new fat from dietary carbohydrates by blocking key enzymatic steps in de novo lipogenesis — preventing fat accumulation while mobilizing existing stores.
Result: Reduced fat storage while existing fat is metabolized
Safe Metabolic Profile
GH-Independent Action
Unlike full GH, AOD-9604 does not bind the GH receptor, does not affect IGF-1 levels, and does not impair insulin sensitivity — making it safe for diabetic patients and those concerned about GH side effects.
Result: Fat loss benefits without GH-related metabolic risks
Clinical Benefits
What you can expect from AOD-9604 therapy
Targeted fat loss
Directly mobilizes stored fat through beta-3 adrenergic activation, targeting visceral and stubborn subcutaneous fat.
Metabolically safe
No IGF-1 elevation, no blood sugar effects, no insulin resistance — safe for diabetics and those on GH-sensitive protocols.
Cardiovascular benefit
Reduced visceral fat produces downstream improvements in insulin sensitivity, lipids, and cardiovascular risk markers.
Anti-obesity activity
Originally developed as an anti-obesity drug — the FDA has reviewed AOD-9604 as a food additive (GRAS status).
Lean mass preservation
Targets fat specifically without catabolizing lean muscle — ideal for body recomposition protocols.
Stacks well
Complements GLP-1 medications, GH secretagogues, and metabolic protocols for comprehensive weight management.
The Process
What to expect & when
Realistic timeline for AOD-9604 results
Weeks 1–4
Metabolic Shift
Lipolytic signaling activates. Some patients notice improved energy as fat oxidation increases.
Weeks 4–8
Visible Fat Loss
Measurable reductions in body fat percentage, particularly in visceral and abdominal areas.
Weeks 8–12
Significant Recomposition
Substantial fat loss with preserved or improved lean mass. Waist circumference typically decreases.
3–6 Months
Peak Results
Maximum body recomposition achieved with sustained protocol use.
Common questions
Everything you need to know about AOD-9604 therapy
Transparent Pricing
Consultation Fees
Physician-guided care with complete pricing clarity.
Generic Consultation
Includes Any & All Services
First Visit
$400
Follow-Up
$150
- Complete health assessment
- All service areas covered
- Personalized treatment plan
- Prescription if appropriate
Specialized Consultation
Skin, Hair, Wellness, Labs, Galleri
First Visit
$300
Follow-Up
$150
- Focused specialty review
- Lab analysis included
- Targeted treatment approach
- Follow-up protocol
Peptide Consultation
Weight loss & metabolic therapies
First Visit
$50
Follow-Up
$30
- Metabolic assessment
- GLP-1 or peptide evaluation
- Dosing strategy
- Prescription included